Factors influencing daily treatment choices in multiple sclerosis: practice guidelines, biomarkers and burden of disease

At two meetings of a Central European board of multiple sclerosis (MS) experts in 2018 and 2019 factors influencing daily treatment choices in MS, especially practice guidelines, biomarkers and burden of disease, were discussed. The heterogeneity of MS and the complexity of the available treatment o...

Descripción completa

Detalles Bibliográficos
Autores principales: Berger, Thomas, Adamczyk-Sowa, Monika, Csépány, Tünde, Fazekas, Franz, Fabjan, Tanja Hojs, Horáková, Dana, Ledinek, Alenka Horvat, Illes, Zsolt, Kobelt, Gisela, Jazbec, Saša Šega, Klímová, Eleonóra, Leutmezer, Fritz, Rejdak, Konrad, Rozsa, Csilla, Sellner, Johann, Selmaj, Krzysztof, Štouracˇ, Pavel, Szilasiová, Jarmila, Turcˇáni, Peter, Vachová, Marta, Vanecková, Manuela, Vécsei, László, Havrdová, Eva Kubala
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Therapeutic Perspectives in Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724259/
https://www.ncbi.nlm.nih.gov/pubmed/33335562
http://dx.doi.org/10.1177/1756286420975223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724259/
https://www.ncbi.nlm.nih.gov/pubmed/33335562
http://dx.doi.org/10.1177/1756286420975223

Ejemplares similares